Literature DB >> 28786060

Bone marrow mesenchymal stem cells ameliorate lung injury through anti-inflammatory and antibacterial effect in COPD mice.

Hong-Mei Liu1, Yi-Tong Liu2, Jing Zhang2, Li-Jun Ma2.   

Abstract

The anti-inflammatory and antibacterial mechanisms of bone marrow mesenchymal stem cells (MSCs) ameliorating lung injury in chronic obstructive pulmonary disease (COPD) mice induced by cigarette smoke and Haemophilus Parainfluenza (HPi) were studied. The experiment was divided into four groups in vivo: control group, COPD group, COPD+HPi group, and COPD+HPi+MSCs group. The indexes of emphysematous changes, inflammatory reaction and lung injury score, and antibacterial effects were evaluated in all groups. As compared with control group, emphysematous changes were significantly aggravated in COPD group, COPD+HPi group and COPD+HPi+MSCs group (P<0.01), the expression of necrosis factor-kappaB (NF-κB) signal pathway and proinflammatory cytokines in bronchoalveolar lavage fluid (BALF) were increased (P<0.01), and the phagocytic activity of alveolar macrophages was downregulated (P<0.01). As compared with COPD group, lung injury score, inflammatory cells and proinflammatory cytokines were significantly increased in the BALF of COPD+HPi group and COPD+HPi+MSCs group (P<0.01). As compared with COPD+HPi group, the expression of tumor necrosis factor-α stimulated protein/gene 6 (TSG-6) was increased, the NF-κB signal pathway was depressed, proinflammatory cytokine was significantly reduced, the anti-inflammatory cytokine IL-10 was increased, and lung injury score was significantly reduced in COPD+HPi+MSCs group. Meanwhile, the phagocytic activity of alveolar macrophages was significantly enhanced and bacterial counts in the lung were decreased. The results indicated cigarette smoke caused emphysematous changes in mice and the phagocytic activity of alveolar macrophages was decreased. The lung injury of acute exacerbation of COPD mice induced by cigarette smoke and HPi was alleviated through MSCs transplantation, which may be attributed to the fact that MSCs could promote macrophages into anti-inflammatory phenotype through secreting TSG-6, inhibit NF-кB signaling pathway, and reduce inflammatory response through reducing proinflammatory cytokines and promoting the expression of the anti-inflammatory cytokine. Simultaneously, MSCs could enhance phagocytic activity of macrophages and bacterial clearance. Meanwhile, we detected anti-inflammatory and antibacterial activity of macrophages regulated by MSCs in vitro. As compared with RAW264.7+HPi+CSE group, the expression of NF-кB p65, IL-1β, IL-6 and TNF-α was significantly reduced, and the phagocytic activity of macrophages was significantly increased in RAW264.7+HPi+CSE+MSCs group (P<0.01). The result indicated the macrophages co-cultured with MSCs may inhibit NF-кB signaling pathway and promote phagocytosis by paracrine mechanism.

Entities:  

Keywords:  chronic obstructive pulmonary disease; inflammation; mesenchymal stem cells

Mesh:

Substances:

Year:  2017        PMID: 28786060     DOI: 10.1007/s11596-017-1763-3

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  31 in total

1.  Apoptosis of alveolar wall cells in chronic obstructive pulmonary disease patients with pulmonary emphysema is involved in emphysematous changes.

Authors:  Hongmei Liu; Lijun Ma; Jizhen Wu; Kai Wang; Xianliang Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-08-07

Review 2.  The Novartis view on emerging drugs and novel targets for the treatment of chronic obstructive pulmonary disease.

Authors:  C Compton; D McBryan; E Bucchioni; F Patalano
Journal:  Pulm Pharmacol Ther       Date:  2013-06-04       Impact factor: 3.410

3.  Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations.

Authors:  Alberto Papi; Cinzia Maria Bellettato; Fausto Braccioni; Micaela Romagnoli; Paolo Casolari; Gaetano Caramori; Leonardo M Fabbri; Sebastian L Johnston
Journal:  Am J Respir Crit Care Med       Date:  2006-02-16       Impact factor: 21.405

4.  Antibiotics in addition to systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease.

Authors:  Johannes M A Daniels; Dominic Snijders; Casper S de Graaff; Fer Vlaspolder; Henk M Jansen; Wim G Boersma
Journal:  Am J Respir Crit Care Med       Date:  2009-10-29       Impact factor: 21.405

5.  Mesenchymal stem cells transplantation protects against rat pulmonary emphysema.

Authors:  Guohua Zhen; Hongmei Liu; Naibing Gu; Huilan Zhang; Yongjian Xu; Zhenxiang Zhang
Journal:  Front Biosci       Date:  2008-05-01

6.  Variations in the management of acute exacerbations of chronic obstructive pulmonary disease.

Authors:  Supna K Sandhu; Jackson Chu; Marko Yurkovich; David Harriman; Catalin Taraboanta; J Mark Fitzgerald
Journal:  Can Respir J       Date:  2013 May-Jun       Impact factor: 2.409

7.  Smoking alters alveolar macrophage recognition and phagocytic ability: implications in chronic obstructive pulmonary disease.

Authors:  Sandra Hodge; Greg Hodge; Jessica Ahern; Hubertus Jersmann; Mark Holmes; Paul N Reynolds
Journal:  Am J Respir Cell Mol Biol       Date:  2007-07-13       Impact factor: 6.914

Review 8.  New anti-inflammatory targets for chronic obstructive pulmonary disease.

Authors:  Peter J Barnes
Journal:  Nat Rev Drug Discov       Date:  2013-07       Impact factor: 84.694

Review 9.  TSG-6: a pluripotent inflammatory mediator?

Authors:  C M Milner; V A Higman; A J Day
Journal:  Biochem Soc Trans       Date:  2006-06       Impact factor: 5.407

Review 10.  Concise Review: Mesenchymal Stem Cells Ameliorate Tissue Injury via Secretion of Tumor Necrosis Factor-α Stimulated Protein/Gene 6.

Authors:  Zhigang He; Jie Hua; Zhenshun Song
Journal:  Stem Cells Int       Date:  2014-12-15       Impact factor: 5.443

View more
  7 in total

1.  Stretch-induced Expression of CYR61 Increases the Secretion of IL-8 in A549 Cells via the NF-κβ/lκβ Pathway.

Authors:  Yan Zhang; Ping Guf; Shang-Long Yao; Dong Yang; Yang Lv; De-Fang Ding
Journal:  Curr Med Sci       Date:  2018-08-20

Review 2.  Chronic obstructive pulmonary disease and asthma: mesenchymal stem cells and their extracellular vesicles as potential therapeutic tools.

Authors:  Hossein Abbaszadeh; Farzaneh Ghorbani; Sanaz Abbaspour-Aghdam; Amin Kamrani; Hamed Valizadeh; Mehdi Nadiri; Armin Sadeghi; Karim Shamsasenjan; Farhad Jadidi-Niaragh; Leila Roshangar; Majid Ahmadi
Journal:  Stem Cell Res Ther       Date:  2022-06-20       Impact factor: 8.079

3.  Effects of bone marrow‑derived mesenchymal stem cell transplantation on chronic obstructive pulmonary disease/obstructive sleep apnea overlap syndrome in rats.

Authors:  Min Chen; Zhaoming Huang; Hong Bi; Xinghua Pan; Jian He; Lewei He; Xu He; Junyi Du; Kaihua Zhou; Liyan Wang; Qing Wang; Xiang Guo; Zhixian Jin
Journal:  Mol Med Rep       Date:  2019-09-30       Impact factor: 2.952

4.  Bone marrow stem cells therapy alleviates vascular injury in a chronic obstructive pulmonary disease‑obstructive sleep apnea overlap syndrome rat model.

Authors:  Hong Bi; Jian He; Xu He; Junyi Du; Min Chen; Zhaoming Huang; Chao Yang; Lijuan Yang; Hang Li; Kaihua Zhou; Qing Wang; Lewei He; Zhixian Jin
Journal:  Mol Med Rep       Date:  2020-11-25       Impact factor: 2.952

5.  Human Umbilical Cord-Derived Mesenchymal Stem Cells Alleviate Acute Lung Injury Caused by Severe Burn via Secreting TSG-6 and Inhibiting Inflammatory Response.

Authors:  Xiaohong Hu; Lingying Liu; Yu Wang; Yonghui Yu; Zhongyuan Li; Yanan Liu; Jiake Chai
Journal:  Stem Cells Int       Date:  2022-02-18       Impact factor: 5.443

Review 6.  Stem Cell-Derived Exosome as Potential Therapeutics for Microbial Diseases.

Authors:  Somayeh Keshtkar; Maryam Kaviani; Saeede Soleimanian; Negar Azarpira; Zahra Asvar; Sara Pakbaz
Journal:  Front Microbiol       Date:  2022-02-14       Impact factor: 5.640

Review 7.  Review of the potential of mesenchymal stem cells for the treatment of infectious diseases.

Authors:  Amit Sharma; Anuja Chakraborty; Bithiah Grace Jaganathan
Journal:  World J Stem Cells       Date:  2021-06-26       Impact factor: 5.326

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.